Cervical Cancer Protection in Japan: Where Are We?
In Japan, government subsidies for human papillomavirus (HPV) vaccination of girls aged 13–16 commenced in 2010. By early 2013, vaccination had become a widely accepted national immunization program. However, in June of 2013, the Ministry of Health, Labor, and Welfare (MHLW), the government’s lead a...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
MDPI AG
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/190d8fd4bd774a779c51292ad396288e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:190d8fd4bd774a779c51292ad396288e |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:190d8fd4bd774a779c51292ad396288e2021-11-25T19:10:41ZCervical Cancer Protection in Japan: Where Are We?10.3390/vaccines91112632076-393Xhttps://doaj.org/article/190d8fd4bd774a779c51292ad396288e2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-393X/9/11/1263https://doaj.org/toc/2076-393XIn Japan, government subsidies for human papillomavirus (HPV) vaccination of girls aged 13–16 commenced in 2010. By early 2013, vaccination had become a widely accepted national immunization program. However, in June of 2013, the Ministry of Health, Labor, and Welfare (MHLW), the government’s lead agency, suspended its recommendation for vaccination in response to reports of adverse vaccine events. The rate of HPV vaccination quickly dropped from 70% to almost zero, where it has lingered for eight years. In 2020, a new 9-valent HPV vaccine was licensed in Japan. The momentum seemed to be building for the resumption of HPV vaccinations, yet Japanese mothers remain widely hesitant about vaccinating their daughters, despite the well-proven safety and efficacy of the HPV vaccines. The Japanese government and our educational and medical institutions must work harder as a team to inform our parents and their children about the life-saving benefits of the HPV vaccine, and at the same time, we must respond to all their concerns and questions. The vaccine hesitancy of unvaccinated women born in 2000 and thereafter is a natural consequence of the suspension of the government‘s recommendation. We must also take every possible measure to reduce the significant risk for cervical cancer these women have.Asami YagiYutaka UedaMamoru KakudaSatoshi NakagawaKosuke HiramatsuAi MiyoshiEiji KobayashiToshihiro KimuraMegumi KurosawaManako YamaguchiSosuke AdachiRisa KudoMasayuki SekineYukio SuzukiAkiko SukegawaSayaka IkedaEtsuko MiyagiTakayuki EnomotoTadashi KimuraMDPI AGarticleHPV vaccinecervical cancergovernment suspension of recommendationadverse eventsvaccine hesitancyMedicineRENVaccines, Vol 9, Iss 1263, p 1263 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
HPV vaccine cervical cancer government suspension of recommendation adverse events vaccine hesitancy Medicine R |
| spellingShingle |
HPV vaccine cervical cancer government suspension of recommendation adverse events vaccine hesitancy Medicine R Asami Yagi Yutaka Ueda Mamoru Kakuda Satoshi Nakagawa Kosuke Hiramatsu Ai Miyoshi Eiji Kobayashi Toshihiro Kimura Megumi Kurosawa Manako Yamaguchi Sosuke Adachi Risa Kudo Masayuki Sekine Yukio Suzuki Akiko Sukegawa Sayaka Ikeda Etsuko Miyagi Takayuki Enomoto Tadashi Kimura Cervical Cancer Protection in Japan: Where Are We? |
| description |
In Japan, government subsidies for human papillomavirus (HPV) vaccination of girls aged 13–16 commenced in 2010. By early 2013, vaccination had become a widely accepted national immunization program. However, in June of 2013, the Ministry of Health, Labor, and Welfare (MHLW), the government’s lead agency, suspended its recommendation for vaccination in response to reports of adverse vaccine events. The rate of HPV vaccination quickly dropped from 70% to almost zero, where it has lingered for eight years. In 2020, a new 9-valent HPV vaccine was licensed in Japan. The momentum seemed to be building for the resumption of HPV vaccinations, yet Japanese mothers remain widely hesitant about vaccinating their daughters, despite the well-proven safety and efficacy of the HPV vaccines. The Japanese government and our educational and medical institutions must work harder as a team to inform our parents and their children about the life-saving benefits of the HPV vaccine, and at the same time, we must respond to all their concerns and questions. The vaccine hesitancy of unvaccinated women born in 2000 and thereafter is a natural consequence of the suspension of the government‘s recommendation. We must also take every possible measure to reduce the significant risk for cervical cancer these women have. |
| format |
article |
| author |
Asami Yagi Yutaka Ueda Mamoru Kakuda Satoshi Nakagawa Kosuke Hiramatsu Ai Miyoshi Eiji Kobayashi Toshihiro Kimura Megumi Kurosawa Manako Yamaguchi Sosuke Adachi Risa Kudo Masayuki Sekine Yukio Suzuki Akiko Sukegawa Sayaka Ikeda Etsuko Miyagi Takayuki Enomoto Tadashi Kimura |
| author_facet |
Asami Yagi Yutaka Ueda Mamoru Kakuda Satoshi Nakagawa Kosuke Hiramatsu Ai Miyoshi Eiji Kobayashi Toshihiro Kimura Megumi Kurosawa Manako Yamaguchi Sosuke Adachi Risa Kudo Masayuki Sekine Yukio Suzuki Akiko Sukegawa Sayaka Ikeda Etsuko Miyagi Takayuki Enomoto Tadashi Kimura |
| author_sort |
Asami Yagi |
| title |
Cervical Cancer Protection in Japan: Where Are We? |
| title_short |
Cervical Cancer Protection in Japan: Where Are We? |
| title_full |
Cervical Cancer Protection in Japan: Where Are We? |
| title_fullStr |
Cervical Cancer Protection in Japan: Where Are We? |
| title_full_unstemmed |
Cervical Cancer Protection in Japan: Where Are We? |
| title_sort |
cervical cancer protection in japan: where are we? |
| publisher |
MDPI AG |
| publishDate |
2021 |
| url |
https://doaj.org/article/190d8fd4bd774a779c51292ad396288e |
| work_keys_str_mv |
AT asamiyagi cervicalcancerprotectioninjapanwherearewe AT yutakaueda cervicalcancerprotectioninjapanwherearewe AT mamorukakuda cervicalcancerprotectioninjapanwherearewe AT satoshinakagawa cervicalcancerprotectioninjapanwherearewe AT kosukehiramatsu cervicalcancerprotectioninjapanwherearewe AT aimiyoshi cervicalcancerprotectioninjapanwherearewe AT eijikobayashi cervicalcancerprotectioninjapanwherearewe AT toshihirokimura cervicalcancerprotectioninjapanwherearewe AT megumikurosawa cervicalcancerprotectioninjapanwherearewe AT manakoyamaguchi cervicalcancerprotectioninjapanwherearewe AT sosukeadachi cervicalcancerprotectioninjapanwherearewe AT risakudo cervicalcancerprotectioninjapanwherearewe AT masayukisekine cervicalcancerprotectioninjapanwherearewe AT yukiosuzuki cervicalcancerprotectioninjapanwherearewe AT akikosukegawa cervicalcancerprotectioninjapanwherearewe AT sayakaikeda cervicalcancerprotectioninjapanwherearewe AT etsukomiyagi cervicalcancerprotectioninjapanwherearewe AT takayukienomoto cervicalcancerprotectioninjapanwherearewe AT tadashikimura cervicalcancerprotectioninjapanwherearewe |
| _version_ |
1718410200847745024 |